Antibody response to inactivated COVID-19 vaccine in patients with type 2 diabetes mellitus after the booster immunization
{{output}}
Background: The immunogenicity of booster inactivated COVID-19 vaccines in patients with type 2 diabetes mellitus (T2DM) has remained unclear. Our study aims to investigate the antibody response to inactivated COVID-19 vaccine fo... ...
